Point72 Asset Management, L.P.

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
E.W. SCRIPPS Co 13G
SSP · 811054402
5.2% 10/5/2026
Event 10/2/2026
Viridian Therapeutics, Inc. 13G
VRDN · 92790C104
5.0% 8/20/2026
Event 8/19/2026
RxSight, Inc. 13G
RXST · 78349D107
6.0% 8/19/2026
Event 8/12/2026
Neuronetics, Inc. 13G
STIM · 64131A105
5.0% 8/14/2026
Event 8/13/2026
Zepp Health Corp 13G/A Amendment 2
ZEPP · 98945L204
0% 8/14/2026
Event 6/30/2026
VNET Group, Inc. 13G/A Amendment 1
VNET · 90138A103
6.6% 8/14/2026
Event 6/30/2026
Sweetgreen, Inc. 13G/A Amendment 1
SG · 87043Q108
3.3% 8/14/2026
Event 6/30/2026
Sutro Biopharma, Inc. 13G/A Amendment 1
STRO · 869367201
1.4% 8/14/2026
Event 6/30/2026
Q32 Bio Inc. 13G/A Amendment 2
QTTB · 746964105
4.95% 8/14/2026
Event 6/30/2026
Power Solutions International, Inc. 13G/A Amendment 1
PSIX · 73933G202
6.5% 8/14/2026
Event 6/30/2026
Janux Therapeutics, Inc. 13G/A Amendment 1
JANX · 47103J105
3.3% 8/14/2026
Event 6/30/2026
HMH Holding Inc 13G/A Amendment 1
HMH · 40445M100
0% 8/14/2026
Event 6/30/2026
Design Therapeutics, Inc. 13G/A Amendment 1
DSGN · 25056L103
3.8% 8/14/2026
Event 6/30/2026
CytomX Therapeutics, Inc. 13G/A Amendment 1
CTMX · 23284F105
3.6% 8/14/2026
Event 6/30/2026
Atara Biotherapeutics, Inc. 13G/A Amendment 1
ATRA · 046513206
7.6% 8/14/2026
Event 6/30/2026
AIB Data Centers Inc. 13G/A Amendment 1
AIB · 093919108
6.6% 8/14/2026
Event 6/30/2026
Evommune, Inc. 13G
EVMN · 30054Y107
5.3% 7/16/2026
Event 7/15/2026
Perceptive Capital Solutions Corp 13G
PCSC · G70077105
5.7% 7/8/2026
Event 7/7/2026
BlockchAIn Digital Infrastructure, Inc. 13G
AIB · 093919108
5.2% 6/25/2026
Event 6/24/2026
Design Therapeutics, Inc. 13G
DSGN · 25056L103
5.1% 6/9/2026
Event 6/8/2026
Avalo Therapeutics, Inc. 13G
AVTX · 05338F306
5.2% 5/26/2026
Event 5/22/2026
Power Solutions International, Inc. 13G
PSIX · 73933G202
5.0% 5/22/2026
Event 5/21/2026
Sweetgreen, Inc. 13G
SG · 87043Q108
6.2% 5/18/2026
Event 5/15/2026
IO Biotech, Inc. 13G/A Amendment 1
IOBTQ · 449778109
0% 5/15/2026
Event 3/31/2026
Q32 Bio Inc. 13G/A Amendment 1
QTTB · 746964105
5.7% 5/15/2026
Event 3/31/2026
OKYO Pharma Ltd 13G/A Amendment 1
OKYO · G6724L116
0% 5/15/2026
Event 3/31/2026
Precigen, Inc. 13G/A Amendment 1
PGEN · 74017N105
1.9% 5/15/2026
Event 3/31/2026
Korro Bio, Inc. 13G/A Amendment 1
KRRO · 500946108
1.9% 5/15/2026
Event 3/31/2026
Tenax Therapeutics, Inc. 13G/A Amendment 2
TENX · 88032L605
3.1% 5/15/2026
Event 3/31/2026
Forte Biosciences, Inc. 13G/A Amendment 1
FBRX · 34962G208
0% 5/15/2026
Event 3/31/2026
Palisade Bio, Inc. 13G/A Amendment 2
PALI · 696389402
0.2% 5/15/2026
Event 3/31/2026
Dianthus Therapeutics, Inc. /DE/ 13G/A Amendment 2
DNTH · 252828108
1.2% 5/15/2026
Event 3/31/2026
Edesa Biotech, Inc. 13G/A Amendment 1
EDSA · 27966L306
0% 5/15/2026
Event 3/31/2026
Design Therapeutics, Inc. 13G/A Amendment 2
DSGN · 25056L103
4.4% 5/15/2026
Event 3/31/2026
Cybin Inc. 13G/A Amendment 3
HELP · 23256X407
1.4% 5/15/2026
Event 3/31/2026
Invivyd, Inc. 13G/A Amendment 3
IVVD · 00534A102
0% 5/15/2026
Event 3/31/2026
Xilio Therapeutics, Inc. 13G/A Amendment 2
XLO · 98422T100
0% 5/15/2026
Event 3/31/2026
KalVista Pharmaceuticals, Inc. 13G/A Amendment 2
KALV · 483497103
4.2% 5/15/2026
Event 3/31/2026
Relay Therapeutics, Inc. 13G/A Amendment 2
RLAY · 75943R102
0% 5/15/2026
Event 3/31/2026
Tonix Pharmaceuticals Holding Corp. 13G/A Amendment 1
TNXP · 890260839
6.9% 5/15/2026
Event 3/31/2026
Anaptysbio, Inc 13G/A Amendment 2
ANAB · 032724106
0.2% 5/15/2026
Event 3/31/2026
Ovid Therapeutics Inc. 13G/A Amendment 1
OVID · 690469101
1.3% 5/15/2026
Event 3/31/2026
Immunome Inc. 13G/A Amendment 1
IMNM · 45257U108
0% 5/15/2026
Event 3/31/2026
C4 Therapeutics, Inc. 13G/A Amendment 1
CCCC · 12529R107
0.2% 5/15/2026
Event 3/31/2026
Damora Therapeutics, Inc. 13G/A Amendment 1
DMRA · 36322Q206
2.0% 5/15/2026
Event 3/31/2026
iBio, Inc. 13G/A Amendment 1
IBIO · 451033708
0% 5/15/2026
Event 3/31/2026
Century Therapeutics, Inc. 13G/A Amendment 2
IPSC · 15673T100
3.3% 5/15/2026
Event 3/31/2026
Syndax Pharmaceuticals Inc 13G/A Amendment 1
SNDX · 87164F105
2.3% 5/15/2026
Event 3/31/2026
Palatin Technologies Inc 13G/A Amendment 1
PTN · 696077601
0.5% 5/15/2026
Event 3/31/2026
Oric Pharmaceuticals, Inc. 13G/A Amendment 1
ORIC · 68622P109
0% 5/15/2026
Event 3/31/2026
Black Rock Coffee Bar, Inc. 13G/A Amendment 1
BRCB · 092244102
4.3% 5/15/2026
Event 3/31/2026
Praxis Precision Medicines, Inc. 13G/A Amendment 8
PRAX · 74006W207
0.2% 5/15/2026
Event 3/31/2026
Lionsgate Studios Corp. 13G/A Amendment 1
LION · 53626N102
2.4% 5/15/2026
Event 3/31/2026
Corvus Pharmaceuticals, Inc. 13G/A Amendment 1
CRVS · 221015100
0% 5/15/2026
Event 3/31/2026
AngioDynamics, Inc. 13G/A Amendment 2
ANGO · 03475V101
7.7% 5/15/2026
Event 3/31/2026
Alto Neuroscience, Inc. 13G/A Amendment 4
ANRO · 02157Q109
3.7% 5/15/2026
Event 3/31/2026
STAAR Surgical Company 13G
STAA · 852312305
5.2% 5/12/2026
Event 5/11/2026
Atara Biotherapeutics, Inc. 13G
ATRA · 046513206
6.2% 5/8/2026
Event 5/7/2026
Sutro Biopharma, Inc. 13G
STRO · 869367201
5.7% 5/1/2026
Event 4/24/2026
Janux Therapeutics, Inc. 13G
JANX · 47103J105
5.0% 4/29/2026
Event 4/28/2026
Janux Therapeutics, Inc. 13G
JANX · 47103J105
5.0% 4/29/2026
Event 4/28/2026
Surrozen, Inc./DE 13G
SRZN · 86889P208
5.4% 4/23/2026
Event 4/22/2026
CytomX Therapeutics, Inc. 13G
CTMX · 23284F105
5.0% 4/16/2026
Event 4/15/2026
HMH Holding Inc 13G
HMH · 40445M100
5.5% 4/6/2026
Event 4/2/2026
Kodiak Sciences Inc. 13G
KOD · 50015M109
1.0% 4/2/2026
Event 3/26/2026
Vera Therapeutics, Inc. 13G
VERA · 92337R101
1.7% 4/1/2026
Event 3/25/2026
Korro Bio, Inc. 13G
KRRO · 500946108
5.7% 3/11/2026
Event 3/10/2026
Celldex Therapeutics, Inc. 13G/A Amendment 1
CLDX · 15117B202
2.6% 3/10/2026
Event 12/31/2025
Edesa Biotech, Inc. 13G
EDSA · 27966L306
7.2% 3/3/2026
Event 2/24/2026
Beta Bionics, Inc. 13G
BBNX · 08659B102
5.2% 2/23/2026
Event 2/18/2026
Q32 Bio Inc. 13G
QTTB · 746964105
9.9% 2/19/2026
Event 2/17/2026
OKYO Pharma Ltd 13G
OKYO · G6724L116
7.9% 2/18/2026
Event 2/17/2026
Century Therapeutics, Inc. 13G/A Amendment 1
IPSC · 15673T100
6.8% 2/17/2026
Event 12/23/2025
Dianthus Therapeutics, Inc. /DE/ 13G/A Amendment 1
DNTH · 252828108
6.9% 2/17/2026
Event 12/31/2025
Kodiak Sciences Inc. 13G/A Amendment 1
KOD · 50015M109
3.5% 2/17/2026
Event 12/31/2025
Wolfspeed, Inc. 13G/A Amendment 1
WOLF · 97785W106
3.8% 2/17/2026
Event 12/31/2025
ADC Therapeutics SA 13G/A Amendment 1
ADCT · H0036K147
4.0% 2/17/2026
Event 12/31/2025
Verastem, Inc. 13G/A Amendment 1
VSTM · 92337C203
1.3% 2/17/2026
Event 12/31/2025
Avalo Therapeutics, Inc. 13G/A Amendment 2
AVTX · 05338F306
3.5% 2/17/2026
Event 12/31/2025
Confluent, Inc. 13G/A Amendment 2
CFLT · 20717M103
0.1% 2/17/2026
Event 12/31/2025
Cidara Therapeutics, Inc. 13G/A Amendment 3
CDTX · 171757206
1.4% 2/17/2026
Event 12/31/2025
FG Nexus Inc. 13G/A Amendment 2
FGNX · 30329Y304
0% 2/17/2026
Event 12/31/2025
Praxis Precision Medicines, Inc. 13G/A Amendment 7
PRAX · 74006W207
6.1% 2/17/2026
Event 12/31/2025
PagSeguro Digital Ltd. 13G/A Amendment 6
PAGS · G68707101
3.8% 2/17/2026
Event 12/31/2025
Alto Neuroscience, Inc. 13G/A Amendment 3
ANRO · 02157Q109
8.9% 2/17/2026
Event 12/31/2025
Korro Bio, Inc. 13G/A Amendment 3
KRRO · 500946108
2.9% 2/17/2026
Event 12/31/2025
Pliant Therapeutics, Inc. 13G/A Amendment 1
PLRX · 729139105
0.1% 2/17/2026
Event 12/31/2025
Palisade Bio, Inc. 13G/A Amendment 1
PALI · 696389402
7.0% 2/17/2026
Event 12/31/2025
IDEAYA Biosciences, Inc. 13G/A Amendment 1
IDYA · 45166A102
2.1% 2/17/2026
Event 12/31/2025
Design Therapeutics, Inc. 13G/A Amendment 1
DSGN · 25056L103
9.4% 2/17/2026
Event 12/31/2025
Wolverine World Wide Inc /DE/ 13G/A Amendment 2
WWW · 978097103
1.5% 2/17/2026
Event 12/31/2025
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
6.8% 2/17/2026
Event 12/31/2025
Invivyd, Inc. 13G/A Amendment 2
IVVD · 00534A102
6.0% 2/17/2026
Event 12/31/2025
Aptevo Therapeutics Inc. 13G/A Amendment 1
APVO · 03835L504
0% 2/17/2026
Event 12/31/2025
IO Biotech, Inc. 13G
IOBTQ · 449778109
5.6% 2/6/2026
Event 2/5/2026
Precigen, Inc. 13G
PGEN · 74017N105
5.2% 1/23/2026
Event 1/22/2026
Infinite Eagle Acquisition Corp. 13G
IEAGU · G4802J129
5.8% 1/21/2026
Event 1/20/2026
Forte Biosciences, Inc. 13G
FBRX · 34962G208
6.3% 1/20/2026
Event 1/12/2026
KalVista Pharmaceuticals, Inc. 13G/A Amendment 1
KALV · 483497103
5.5% 1/13/2026
Event 1/5/2026
KalVista Pharmaceuticals, Inc. 13G
KALV · 483497103
4.9% 1/12/2026
Event 1/5/2026